Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The c-mesenchymal-epithelial transition factor (c-MET) is a receptor tyrosine kinase involved in cell growth, survival, and motility. It plays a crucial role in embryonic development and tissue regeneration. Aberrant activation of c-MET contributes to tumorigenesis, making it a therapeutic target in various cancers.
Tyrosine kinase inhibitor
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on c-mesenchymal-epithelial transition factor (c-MET).